The University of Tokyo

Other

Yuzuru Homma

Kazuo Okada

Takeshi Shimizu

Hiroshi Shionoya

Chiyoji Abe

Mink infection caused by Pseudomonas aeruginosa can be prevented by administering to mink a prophylactic preparation in the form of vaccine whose effective component is a compound mainly consisting of protein and a small amount of lipid and sugar derived from Pseudomonas aeruginosa.

Prophylactic preparation for treating mink infection caused by

A therapeutic preparation of a bacterial component (designated as OEP and formally as CWP) derived from Pseudomonas aeruginosa possesses vaccine activity (the effective component being a lipoprotein of Pseudomonas aeruginosa) or the same containing antibiotics is effective in the treatment of mink hemorrhagic pneumonitis and bovine mastitis due to Pseudomonas aeruginosa.

Therapeutical method for treating infection of mink hemorrhagic

The invention involves vaccine preparations comprising cell wall protein component of Pseudomonas aeruginosa as active ingredient and a pharmaceutically acceptable carrier. The preparations are suitable for parenteral administration for prophylactic treatment of disease caused by infection of Pseudomonas aeruginosa. The cell wall protein component is characterized by the fact that the same exhibits low toxicity and without type-specificity to the variety of antigens of Pseudomonas aeruginosa.

Growing community of inventors

Tokyo, Japan

Yuzuru Homma